A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Abraxane and Gemcitabine
Sponsor: Fudan University